Aijun Xu

748 total citations
36 papers, 561 citations indexed

About

Aijun Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Aijun Xu has authored 36 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Surgery. Recurrent topics in Aijun Xu's work include Cardiac Ischemia and Reperfusion (6 papers), Pain Mechanisms and Treatments (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Aijun Xu is often cited by papers focused on Cardiac Ischemia and Reperfusion (6 papers), Pain Mechanisms and Treatments (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Aijun Xu collaborates with scholars based in China, United States and United Kingdom. Aijun Xu's co-authors include Edward J. Lesnefsky, Ying Hu, Qun Chen, T Ross, Beibei Wang, Jinxu Wang, Ludovic Gomez, M. Paillard, Karol Szczepanek and Yuke Tian and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Neurophysiology.

In The Last Decade

Aijun Xu

33 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aijun Xu China 15 253 132 97 59 55 36 561
Fereshteh Golab Iran 16 251 1.0× 116 0.9× 96 1.0× 96 1.6× 82 1.5× 45 795
Dhiraj G. Kabra Germany 15 305 1.2× 241 1.8× 59 0.6× 45 0.8× 75 1.4× 21 849
Xianghu He China 15 194 0.8× 79 0.6× 89 0.9× 107 1.8× 43 0.8× 29 538
Juan Zhu China 15 236 0.9× 88 0.7× 51 0.5× 78 1.3× 41 0.7× 28 682
Jianping Tao China 11 212 0.8× 70 0.5× 178 1.8× 79 1.3× 131 2.4× 25 763
Birsen Elibol Türkiye 15 211 0.8× 242 1.8× 55 0.6× 71 1.2× 28 0.5× 52 807
Jianjuan Ke China 16 262 1.0× 206 1.6× 104 1.1× 64 1.1× 88 1.6× 31 760
Farhad Ghadiri Soufi Iran 14 233 0.9× 160 1.2× 49 0.5× 20 0.3× 37 0.7× 27 631
Jacqueline M. Lopes de Faria Brazil 21 388 1.5× 168 1.3× 134 1.4× 34 0.6× 76 1.4× 34 1.3k

Countries citing papers authored by Aijun Xu

Since Specialization
Citations

This map shows the geographic impact of Aijun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Xu more than expected).

Fields of papers citing papers by Aijun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aijun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Xu. The network helps show where Aijun Xu may publish in the future.

Co-authorship network of co-authors of Aijun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Aijun Xu. A scholar is included among the top collaborators of Aijun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aijun Xu. Aijun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ge, Liu, Lu Cao, Mengna Liu, et al.. (2025). Assessment of six surrogate insulin resistance indexes for predicting hypertension risk in rural Chinese adults. Hypertension Research. 48(4). 1285–1294. 1 indexed citations
3.
Wu, Yuying, et al.. (2025). Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study. Cardiovascular Diabetology. 24(1). 349–349.
4.
Zhou, Siqi, et al.. (2025). Analysis of factors associated with polyuria in spinal surgery: a retrospective study. BMC Anesthesiology. 25(1). 199–199.
5.
Zhou, Siqi, et al.. (2023). α5GABAA receptor: A potential therapeutic target for perioperative neurocognitive disorders, a review of preclinical studies. Brain Research Bulletin. 205. 110821–110821. 2 indexed citations
6.
Wang, Beibei, Jin‐Sheng Zhang, & Aijun Xu. (2023). Recombinant Adenovirus siRNA Knocking Down the Ndufs4 Gene Alleviates Myocardial Apoptosis Induced by Oxidative Stress Injury. Cardiology Research and Practice. 2023. 1–8. 1 indexed citations
7.
Xu, Aijun, et al.. (2023). Perfusion index for early identification of regional anesthesia effectiveness: a narrative review. Minerva Anestesiologica. 89(7-8). 671–679. 3 indexed citations
8.
Wang, Beibei, et al.. (2022). Blocking the Aryl Hydrocarbon Receptor Alleviates Myocardial Ischemia/Reperfusion Injury in Rats. Current Medical Science. 42(5). 966–973. 6 indexed citations
9.
Zhou, Ya‐Qun, Dai-Qiang Liu, Cheng Liu, et al.. (2022). Targeting α7 nicotinic acetylcholine receptors for chronic pain. Frontiers in Molecular Neuroscience. 15. 970040–970040. 7 indexed citations
10.
Xu, Aijun, et al.. (2022). Association between preoperative hypokalemia and postoperative complications in elderly patients: a retrospective study. BMC Geriatrics. 22(1). 743–743. 4 indexed citations
11.
Wang, Jinxu, et al.. (2022). Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 150. 113006–113006. 38 indexed citations
12.
Wang, Beibei & Aijun Xu. (2018). Aryl hydrocarbon receptor pathway participates in myocardial ischemia reperfusion injury by regulating mitochondrial apoptosis. Medical Hypotheses. 123. 2–5. 24 indexed citations
13.
Wang, Jiajun, Aijun Xu, Junying Zhang, et al.. (2016). Prognostic significance of long non-coding RNA MALAT-1 in various human carcinomas: a meta-analysis. Genetics and Molecular Research. 15(1). 20 indexed citations
14.
Szczepanek, Karol, Aijun Xu, Ying Hu, et al.. (2015). Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury. Basic Research in Cardiology. 110(6). 53–53. 38 indexed citations
15.
Xu, Aijun, Karol Szczepanek, Ying Hu, Edward J. Lesnefsky, & Qun Chen. (2013). Cardioprotection by modulation of mitochondrial respiration during ischemia–reperfusion: Role of apoptosis-inducing factor. Biochemical and Biophysical Research Communications. 435(4). 627–633. 22 indexed citations
16.
Bu, Huilian, Cheng Liu, Feng Gao, et al.. (2012). Inhibition of glial activation in rostral ventromedial medulla attenuates mechanical allodynia in a rat model of cancer-induced bone pain. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(2). 291–298. 34 indexed citations
17.
Chen, Qun, M. Paillard, Ludovic Gomez, et al.. (2011). Activation of mitochondrial μ-calpain increases AIF cleavage in cardiac mitochondria during ischemia–reperfusion. Biochemical and Biophysical Research Communications. 415(4). 533–538. 81 indexed citations
18.
Cao, Fei, Feng Gao, Aijun Xu, et al.. (2010). Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain. Brain Research. 1326. 162–173. 29 indexed citations
20.
Xu, Aijun, et al.. (2007). Effects of intracerebroventricular NMDA and non-NMDA receptor agonists or antagonists on general anesthesia of propofol in mice. Frontiers of Medicine in China. 1(2). 207–210. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026